Why is US facing shortage of FDA approved drug Adderall?

The US currently faces a shortage of Adderall that is used to treat attention deficit hyperactivity disorder (ADHD). There has been an increasing demand for the drug since the Covid-19 pandemic, and pharmacies are finding it challenging to stock the product.

Adderall is a US Food Drug and Drug Administration (FDA) approved drug which consists of a combination of dextroamphetamine and amphetamine. It is also used to treat narcolepsy, which causes daytime sleepiness.





ADHD is one of the most commonly found neurodevelopmental disorders in children. Children suffering from ADHD struggle with being attentive and controlling their impulsive behaviour and can be highly active.

ADHD can also continue to adulthood and cause difficulty maintaining relationships or focusing on work. Adderall, as a stimulant, can improve concentration levels and control hyperactivity by increasing dopamine and norepinephrine levels in the brain.

It is declared a schedule II drug in the US, meaning it can also be used for drug abuse. Manufacturing delays and labour shortages cause a shortage in supply.

FAQs

What is Adderall?
Adderall is a stimulant which consists of dextroamphetamine and amphetamine. It is used to treat ADHD.

What is narcolepsy?
Narcolepsy is a sleep condition where a person experiences daytime sleepiness.

Why is there a short supply of Adderall in the US?
Due to labour shortages and manufacturing delays, the US is facing a short supply of Adderall.